Scarica l'app Stockscreener
2.905
1.02%
-0.025
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Briacell Therapeutics Corp Borsa (BCTX) Ultime notizie
BriaCell Reports Increased Losses in Latest Financials - TipRanks
(BCT) Advanced Trading Insights (BCT:CA) - news.stocktradersdaily.com
Briacell Therapeutics Corp expected to post a loss of $1.76 a shareEarnings Preview - TradingView
Learn to Evaluate (BCT) using the Charts (BCT:CA) - news.stocktradersdaily.com
(BCT) Strategic Equity Report (BCT:CA) - news.stocktradersdaily.com
(BCT) Investment Analysis and Advice (BCT:CA) - news.stocktradersdaily.com
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewswire
(BCT) Pivots Trading Plans and Risk Controls (BCT:CA) - news.stocktradersdaily.com
Stocks In Play - Baystreet.ca
Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025 - TipRanks
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 | BCTX Stock News - GuruFocus
BriaCell’s Bria-IMT Shows Strong Survival & Benefit in Advanced Breast Cancer - Insider Monkey
Stocks In Play: BriaCell Therapeutics Corp. By Baystreet.ca - Investing.com Canada
Stocks In Play: BriaCell Therapeutics Corp. - Barchart.com
BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies - TipRanks
BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | B - GuruFocus
BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | BCTX Stock News - GuruFocus
BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times
Clinical Trial Success: BriaCell's Breast Cancer Treatment Outperforms FDA-Approved Therapies at ASCO 2025 - Stock Titan
(BCT) Stock Market Analysis (BCT:CA) - news.stocktradersdaily.com
(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BC - GuruFocus
BriaCell Therapeutics (NASDAQ:BCTX) Stock Price Up 1.6% – Should You Buy? - Defense World
When (BCT) Moves Investors should Listen (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics Corp - Baystreet.ca
Cardiol Therapeutics Inc. - Baystreet.ca
BriaCell advances cancer treatment with Bria-OTS in clinical study By Investing.com - Investing.com South Africa
BriaCell Bria-OTS? Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - marketscreener.com
BriaCell advances cancer treatment with Bria-OTS in clinical study - Investing.com
BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase - TipRanks
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Dos - GuruFocus
BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BCTX Stock News - GuruFocus
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety - GlobeNewswire
BriaCell's Breast Cancer Immunotherapy Shows Early Success: Patient's Lung Metastasis Completely Resolved - Stock Titan
(BCT) Advanced Equity Analysis (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail
BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Sto - GuruFocus
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment - TipRanks
BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week - marketscreener.com
BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Stock News - GuruFocus
BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times
‘Don’t Doubt UNH Yet,’ Top JPMorgan Analyst Defends UnitedHealth Stock amid Recent Volatility - The Globe and Mail
Breakthrough: BriaCell's New Breast Cancer Drug Shows 13.4-Month Survival Rate, Beating Standard Therapies - Stock Titan
OpenAI CEO Sam Altman Admits Even They Are ‘a Little Bit Scared’ of What They’re Building—But That’s a Good Thing - The Globe and Mail
Stock Market News Today, 5/22/25 – Futures Flat, Post Deficit-Fear-Driven Sell-Off - The Globe and Mail
Moderna Stock Looks Ripe for a Short Squeeze - The Globe and Mail
(BCT) Trading Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell CEO Letter to Shareholders | BCTX Stock News - GuruFocus
BriaCell (BCTX) Reports Promising Advances in Cancer Treatment Studies | BCTX Stock News - GuruFocus
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results - TipRanks
Briacell Therapeutics CorpBria-Imt Receives FDA Fast Track Designation For Phase 3 Study - marketscreener.com
BriaCell CEO Letter to Shareholders - GlobeNewswire
Clinical Trial Breakthrough: BriaCell's Breast Cancer Therapy Shows 83% Success Rate, Surpassing Current Standard - Stock Titan
Public market insider buying at CGI (GIB) - The Globe and Mail
BriaCell Therapeutics (OTCMKTS:BCTXF) Stock Price Up 0.7% – Here’s Why - Defense World
Cisco Systems: A Safe Investment or a Stagnant Giant? - The Globe and Mail
(BCT) On The My Stocks Page (BCT:CA) - news.stocktradersdaily.com
0.34%
7.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):